Forman v. Novartis Pharmaceuticals Corp.
District Court, E.D. New York
1Opinion of the Court
MEMORANDUM OF DECISION AND ORDER
SPATT, District Judge.
Presently before the Court is a motion by the defendant Novartis Pharmaceuticals Corporation (“NPC”) seeking to prevent the plaintiff Beth Forman (“the Plaintiff’) from pursuing punitive damages at the trial of the above-captioned ease on the grounds that: (1) federal law prohibits the Plaintiff from obtaining punitive damages under the relevant New Jersey statutes; (2) the Plaintiff lacks standing to pursue punitive damages under the relevant New Jersey statutes; and (3) the Plaintiffs evidence is insufficient to raise a genuine issue of…
2Cases cited24 opinions
- Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
- Wyeth v. LevineSupreme Court of the United States · 2009
- Silkwood v. Kerr-McGee Corp.Supreme Court of the United States · 1984
- Crosby v. National Foreign Trade CouncilSupreme Court of the United States · 2000
- Gade v. National Solid Wastes Management Assn.Supreme Court of the United States · 1992
19 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Davids v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2012
- Zimmerman v. Novartis Pharmaceuticals Corp.District Court, D. Maryland · 2012
- Rowland v. Novartis Pharmaceuticals Corp.District Court, W.D. Pennsylvania · 2013
- Stromenger v. Novartis Pharmaceuticals Corp.District Court, D. Oregon · 2013
- Mathews v. Novartis Pharmaceuticals Corp.District Court, S.D. Ohio · 2013
3 more not listed; retrieve them via the Exa API.